Association of interferon regulatory factor 5 (IRF5) markers with an increased risk of lupus and overlapping autoimmunity in a Kuwaiti population

References

• Barnes BJ, Moore PA, Pitha PM. 2001. Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J Biol Chem 276:23382–23390
   PubMed Web of Science ®Google Scholar
• Barnes BJ, Richards J, Mancl M, Hanash S, Beretta L, Pitha PM. 2004. Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J Biol Chem 279:45194–45207
   PubMed Web of Science ®Google Scholar
• Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265
   Google Scholar
• Cheng T-S, Brzostek S, Ando O, Van Scoy S, Kumar KP, Reich NC. 2006. Differential activation of IFN regulatory factor (IRF)-3 and IRF-5 transcription factors during viral infection. J Immunol 176:7462–7470
   PubMed Web of Science ®Google Scholar
• Crow MK. 2005. Interferon pathway activation in systemic lupus erythematosus. Curr Rheumatol Rep 7:463–468
   PubMedGoogle Scholar
• Dall’era, MC, Cardarelli PM, Preston BT, Witte A, Davis JC. 2005. Type I interferon correlates with serological and clinical manifestations of SLE. Ann Rheum Dis 64:1692–1697
   PubMed Web of Science ®Google Scholar
• Demirci FY, Manzi S, Ramsey-Goldman R, Minster RL, Kenney M, Shaw PS, Dunlop-Thomas CM, et al. 2007. Association of a common interferon regulatory factor 5 (irf5) variant with increased risk of systemic lupus erythematosus (sle). Ann Hum Genet 71:308–311
   PubMed Web of Science ®Google Scholar
• Feng D, Stone RC, Eloranta ML, Sangster-Guity N, Nordmark G, Sigurdsson S, Wang C, et al. 2010. Genetic variants and disease-associated factors contribute to enhanced IRF-5 expression in blood cells of systemic lupus erythematosus patients. Arthritis Rheum 62:562–573
   PubMedGoogle Scholar
• Graham DSC, Manku H, Wagner S, Reid J, Timms K, Gutin A, Lanchbury JS, Vyse TJ. 2007. Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation. Hum Mol Genet 16:579–591
   PubMedGoogle Scholar
• Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, Bauer JW, Ortmann WA, et al. 2006. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 38:550–555
   PubMed Web of Science ®Google Scholar
• Hellquist A, Järvinen TM, Koskenmies S, Zucchelli M, Orsmark-Pietras C, Berglind L, Panelius J, et al. 2009. Evidence for genetic association and interaction between the tyk2 and irf5 genes in systemic lupus erythematosus. J Rheumatol 36:1631–1638
   PubMed Web of Science ®Google Scholar
• Hochberg MC. 1997. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
   PubMed Web of Science ®Google Scholar
• Hu G, Mancl ME, Barnes BJ. 2005. Signaling through IFN regulatory factor-5 sensitizes p53-deficient tumors to DNA damage-induced apoptosis and cell death. Cancer Res 15:7403–7412
   Google Scholar
• Hu W, Ren H. 2011. A meta-analysis of the association of IRF5 polymorphism with systemic lupus erythematosus. Int J Immunogenet 38:411–417
   PubMedGoogle Scholar
• Kawasaki A, Kyogoku C, Ohashi J, Miyashita R, Hikami K, Kusaoi M, Tokunaga K, et al. 2008. Association of irf5 polymorphisms with systemic lupus erythematosus in a japanese population: support for a crucial role of intron 1 polymorphisms. Arthritis Rheum 58:826–834
   PubMed Web of Science ®Google Scholar
• Kelly JA, Kelley JM, Kaufman KM, Kilpatrick J, Bruner GR, Merrill JT, James JA, et al. 2008. Interferon regulatory factor-5 is genetically associated with systemic lupus er ythematosus in African Americans. Genes Immun 9:187–194
   PubMed Web of Science ®Google Scholar
• Kozyrev SV, Lewén S, Reddy PM, Pons-Estel B, Witte T, Junker P, Laustrup H, et al. 2007. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheum 56:1234–1241
   PubMed Web of Science ®Google Scholar
• Löfgren SE, Yin H, Delgado-Vega AM, Sanchez E, Lewen S, Pons-Estel BA, Witte T, et al. 2010. Promoter insertion/deletion in the irf5 gene is highly associated with susceptibility to systemic lupus erythematosus in distinct populations, but exerts a modest effect on gene expression in peripheral blood mononuclear cells. J Rheumatol 37:574–578
   PubMedGoogle Scholar
• Mancl ME, Hu G, Sangster-Guity N, Olshalsky SL, Hoops K, Fitzgerald-Bocarsly P, Pitha PM, et al. 2005. Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms Multiple isoforms with distinct cell typespecific expression, localization, regulation, and function. J Biol Chem 280:21078–21090
   PubMed Web of Science ®Google Scholar
• Nath SK, Kilpatrick J, Harley B. 2004. Genetics of human systemic lupus erythematosus: the emerging picture. Curr Opin Immunol 16:794–800
   PubMedGoogle Scholar
• Pitha Rowe P, Roy S. 2012. IRF-5; Mediates cross talk between innate and adaptive immunity. Cytokine 59:499–500
   Google Scholar
• Raymond M, Rousset F. 1995. GENEPOP (version 12): population genetics software for exact tests and ecumenicism. J Heredity 86:248–249
   Web of Science ®Google Scholar
• Reddy MV, Velázquez-Cruz R, Baca V, Lima G, Granados J, Orozco L, Alarcón-Riquelme ME. 2007. Genetic association of IRF5 with SLE in Mexicans. Hum Genet 121:721–727
   PubMedGoogle Scholar
• Shin HD, Sung YK, Choi CB, Lee SO, Lee HW, Bae SC. 2007. Replication of the genetic effects of ifn regulatory factor 5 (irf5) on systemic lupus erythematosus in a Korean population. Arthritis Res Ther 9:R32
   PubMed Web of Science ®Google Scholar
• Sigurdsson S, Göring HH, Kristjansdottir G, Milani L, Nordmark G, Sandling JK, Eloranta ML, et al. 2008. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum Mol Genet 17:872–881
   PubMed Web of Science ®Google Scholar
• Sigurdsson S, Nordmark G, Göring HH, Lindroos K, Wiman AC, Sturfelt G, Jönsen A, et al. 2005. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 76:528–537
   PubMed Web of Science ®Google Scholar
• Siu HO, Yang W, Lau CS, Chan TM, Wong RW, Wong WH, Lau YL, Alarcon-Riquelme ME. 2008. Association of a haplotype of irf5 gene with systemic lupus erythematosus in Chinese. J Rheumatol 35:360–362
   PubMed Web of Science ®Google Scholar
• Song WQ, Li HH, Chen HB, Yuan JS, Yin XJ. 2009. Relationship between polymorphism sites of irf5, tlr-9 and sle patients in shandong han population. Zhonghua Yi Xue Za Zhi 89:303–342
   Google Scholar
• Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T, Kano S, et al. 2005. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434:243–249
   PubMed Web of Science ®Google Scholar